Explore the library
Limited human evidenceBotanical isoquinoline alkaloid

Berberine

Berberine is a plant-derived compound studied for metabolic effects. Preliminary glucose and lipid findings do not make it a substitute for metformin or an approved weight-loss drug.

Also indexed as: Plant isoquinoline alkaloid

A clear starting point

Researchers study how berberine affects energy handling and blood markers. Some small trials show changes, but larger, better-controlled studies are needed to know which benefits are reliable.

Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.

No validated chemical structure is displayed in this edition.

How it works

Cellular energy sensing / AMPK-associated research / gut effects

Researchers study how berberine affects energy handling and blood markers. Some small trials show changes, but larger, better-controlled studies are needed to know which benefits are reliable.

Targets & processes
Multiple experimental pathways; no single validated target explains all human claims
Systems & tissues
Intestine, liver and metabolic tissues in research.

What does the evidence show?

Some human studies report glucose and lipid-marker improvements. Rigorous evidence for meaningful durable weight loss is insufficient.

What this does not establish

Short studies and surrogate outcomes do not establish long-term complications reduction or equivalence to approved medicines.

NCCIH: In the News — Berberine

Official educational / regulatory source · Official educational / regulatory source

Some supportive metabolic research; rigorous weight-loss evidence is insufficient. Gastrointestinal effects and medicine interactions; avoid during pregnancy, breastfeeding and in infants.

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.

The Journal of clinical endocrinology and metabolism · 2008 · Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't · PMID 18397984

Verified sample: 116 · Adults with type 2 diabetes and dyslipidemia

Glucose and lipid markers improved over three months.

Limitations: Short trial, surrogate outcomes; not proof of equivalence to metformin or long-term cardiovascular benefit.

Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.

Safety is a separate question

Abdominal pain, constipation, diarrhea, nausea and vomiting can occur. Clinically important medicine interactions are possible.

Contraindications & cautions

Avoid during pregnancy or breastfeeding and do not give to infants; newborn jaundice/kernicterus is a concern.

Medication & supplement interactions

Can interact with medicines, including glucose-lowering and immunosuppressant therapies. A pharmacist should assess the specific combination.

Regulatory status · United States

United States: sold as a dietary supplement, not an FDA-approved drug for disease treatment. Ingredient research does not validate every marketed product.

This is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.

Make the science interactive

A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.

Your scientific classroom

Ask the IW Science Instructor

Basic level · Published sources only · AI evidence check

Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.

Answers checked before they appear
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.

Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.